Cargando…

Patient satisfaction with glaucoma therapy: reality or myth?

While safe and effective treatments for glaucoma exist, their effectiveness is compromised by poor compliance. Patients who have problems with their topical glaucoma medication are acknowledged to be at higher risk for poor compliance, frequent medication switching, and surgery. Patient satisfaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemij, Hans G, Hoevenaars, Juliette GMM, van der Windt, Cees, Baudouin, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427261/
https://www.ncbi.nlm.nih.gov/pubmed/25999687
http://dx.doi.org/10.2147/OPTH.S78918
_version_ 1782370699367677952
author Lemij, Hans G
Hoevenaars, Juliette GMM
van der Windt, Cees
Baudouin, Christophe
author_facet Lemij, Hans G
Hoevenaars, Juliette GMM
van der Windt, Cees
Baudouin, Christophe
author_sort Lemij, Hans G
collection PubMed
description While safe and effective treatments for glaucoma exist, their effectiveness is compromised by poor compliance. Patients who have problems with their topical glaucoma medication are acknowledged to be at higher risk for poor compliance, frequent medication switching, and surgery. Patient satisfaction with therapy and its associated benefits have until recently taken second place to efficacy. The present study is a transverse cross-sectional epidemiological survey among glaucoma patients receiving therapy with prostaglandin analogs. The primary objective was to determine and characterize patient satisfaction with glaucoma therapy, and the secondary objective was to identify factors that may contribute to poor patient satisfaction. Ophthalmologists in the Netherlands included 199 patients and 164 were analyzed. Patients were predominantly elderly with early, primary, open angle glaucoma. Eighty-nine percent of them stated they were satisfied or very satisfied with their treatment. However, signs of ocular surface disorder on ophthalmological examination were evident in 44% of patients, corneal fluorescein staining was positive in 28% of patients, and 38% of patients were using tear substitutes. The prevalence of blepharitis/meibomian gland dysfunction and dry eye was more than twice as high after the commencement of therapy compared with before therapy. Univariate analysis revealed that patient dissatisfaction with their glaucoma therapy was statistically significantly (P<0.001) associated with the presence of ocular surface disease, hyperemia, ocular signs, symptoms upon and between instillation, and the use of tear substitutes. Apparently, patients in the present study are satisfied with their treatment; 89% expressed satisfaction compared with only 11% who professed dissatisfaction. The results suggest that even if local adverse events and ocular surface disease, in particular, contribute to glaucoma patient dissatisfaction, only a minority of patients expressed such dissatisfaction. At the time of the study, most (94%) of the patients included were receiving preserved preparations. Further studies should evaluate the influence of preservative on patient satisfaction.
format Online
Article
Text
id pubmed-4427261
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44272612015-05-21 Patient satisfaction with glaucoma therapy: reality or myth? Lemij, Hans G Hoevenaars, Juliette GMM van der Windt, Cees Baudouin, Christophe Clin Ophthalmol Original Research While safe and effective treatments for glaucoma exist, their effectiveness is compromised by poor compliance. Patients who have problems with their topical glaucoma medication are acknowledged to be at higher risk for poor compliance, frequent medication switching, and surgery. Patient satisfaction with therapy and its associated benefits have until recently taken second place to efficacy. The present study is a transverse cross-sectional epidemiological survey among glaucoma patients receiving therapy with prostaglandin analogs. The primary objective was to determine and characterize patient satisfaction with glaucoma therapy, and the secondary objective was to identify factors that may contribute to poor patient satisfaction. Ophthalmologists in the Netherlands included 199 patients and 164 were analyzed. Patients were predominantly elderly with early, primary, open angle glaucoma. Eighty-nine percent of them stated they were satisfied or very satisfied with their treatment. However, signs of ocular surface disorder on ophthalmological examination were evident in 44% of patients, corneal fluorescein staining was positive in 28% of patients, and 38% of patients were using tear substitutes. The prevalence of blepharitis/meibomian gland dysfunction and dry eye was more than twice as high after the commencement of therapy compared with before therapy. Univariate analysis revealed that patient dissatisfaction with their glaucoma therapy was statistically significantly (P<0.001) associated with the presence of ocular surface disease, hyperemia, ocular signs, symptoms upon and between instillation, and the use of tear substitutes. Apparently, patients in the present study are satisfied with their treatment; 89% expressed satisfaction compared with only 11% who professed dissatisfaction. The results suggest that even if local adverse events and ocular surface disease, in particular, contribute to glaucoma patient dissatisfaction, only a minority of patients expressed such dissatisfaction. At the time of the study, most (94%) of the patients included were receiving preserved preparations. Further studies should evaluate the influence of preservative on patient satisfaction. Dove Medical Press 2015-05-04 /pmc/articles/PMC4427261/ /pubmed/25999687 http://dx.doi.org/10.2147/OPTH.S78918 Text en © 2015 Lemij et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lemij, Hans G
Hoevenaars, Juliette GMM
van der Windt, Cees
Baudouin, Christophe
Patient satisfaction with glaucoma therapy: reality or myth?
title Patient satisfaction with glaucoma therapy: reality or myth?
title_full Patient satisfaction with glaucoma therapy: reality or myth?
title_fullStr Patient satisfaction with glaucoma therapy: reality or myth?
title_full_unstemmed Patient satisfaction with glaucoma therapy: reality or myth?
title_short Patient satisfaction with glaucoma therapy: reality or myth?
title_sort patient satisfaction with glaucoma therapy: reality or myth?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427261/
https://www.ncbi.nlm.nih.gov/pubmed/25999687
http://dx.doi.org/10.2147/OPTH.S78918
work_keys_str_mv AT lemijhansg patientsatisfactionwithglaucomatherapyrealityormyth
AT hoevenaarsjuliettegmm patientsatisfactionwithglaucomatherapyrealityormyth
AT vanderwindtcees patientsatisfactionwithglaucomatherapyrealityormyth
AT baudouinchristophe patientsatisfactionwithglaucomatherapyrealityormyth